Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Sika manufactures specialty chemicals and systems that increase the effective materials content per construction project. With steady end-market fundamentals, price and mix levers, and a track record of share gains, Sika sets up as a compounder inside a construction cycle. This trade idea outlines an actionable long entry, stop, and target, framed …
Walmart plunged after a weak comp-sales print on 08/20/2026, but a deeper look at valuation and margin pressure argues the sell-off did not fully correct for slowing growth. This trade idea recommends a tactical short with a mid-term horizon, precise entry, stop and target, and clear risk controls.
BriaCell Therapeutics Corp. announced progress in its personalized off-the-shelf immunotherapy vaccine candidate Bria-MEL+ for melanoma, highlighting the achievement of a key genetic engineering milestone advancing the program toward clinical trials. This vaccine leverages patient-specific HLA matching without individualized manufacturing, aiming t…
CoinShares PLC will hold a virtual Extraordinary General Meeting on September 15, 2026, to consider resolutions including authorization for market purchases of up to 25% of its ordinary shares, adoption of a new 2026 Equity Incentive Plan to include US tax-qualified Incentive Stock Options, and approval of a French tax-qualified free share scheme u…
BridgeBio Pharma announced the presentation of new data on acoramidis, its oral transthyretin stabilizer for treating transthyretin amyloid cardiomyopathy (ATTR-CM), at the ESC Congress 2026. The data reinforce acoramidis as the first-line treatment choice, highlighting survival benefits, improved myocardial functions, and enhanced quality of life.…
Arbutus Biopharma Corp. announced a modified Dutch auction tender offer to repurchase up to $230 million of its common shares, representing approximately 20.2% to 23.2% of outstanding shares. The offer price range is $5.00 to $5.75 per share, funded from cash on hand following a $178 million settlement payment from Moderna. The tender offer provide…
Crane NXT, a global industrial technology company, has appointed Jason Lund as President of Crane Payment Innovations and Group President of its Detection and Traceability Technologies segment. Lund brings extensive experience in leading industrial technology businesses and will focus on growth, operational excellence, and customer innovation withi…
Gogoro Inc., a leader in battery-swapping electric mobility and a Nasdaq-listed company, announced the retirement of its longtime Chief Financial Officer Bruce Aitken effective September 1, 2026. Jacky Lee, with extensive experience in finance and operations, has been appointed as the new Principal Financial Officer. Leadership expressed confidence…
Bloom Energy's factory-built solid oxide fuel cells have become a preferred quick-deploy power source for AI-heavy data centers. With Q2 revenue topping $1.065 billion and a $20 billion backlog, the company is converting scale and product innovation into revenue growth. The stock is richly valued, but the recent pullback and the rollout of Power Co…
VERAXA Biotech AG and Secarna Pharmaceuticals announced promising initial results from their collaboration developing antibody oligonucleotide conjugates (AOCs), showing enhanced potency in early in vitro studies. This milestone underscores the therapeutic potential of AOCs to improve targeted treatments for autoimmune and chronic immune diseases. …
Lithium Argentina has finalized a joint venture with Ganfeng Lithium to consolidate three lithium projects in Argentina into the PPG JV, targeting 150,000 tonnes per annum of lithium carbonate equivalent. Ganfeng will invest $180 million via a convertible note, strengthening Lithium Argentina's balance sheet by enabling the repayment of $259 millio…
Mesoblast Limited, an innovator in allogeneic cellular therapies, will host a webcast to discuss its FY 2026 financial results and operational updates. The company, with products including the FDA-approved Ryoncil® for steroid-refractory acute graft versus host disease, continues to develop multiple therapies for inflammatory and cardiac conditions…
Tiziana Life Sciences announced a poster presentation detailing the Phase 2a BANYAN clinical trial of intranasal foralumab for ALS treatment. The trial, part of the Healey ALS MyMatch program, evaluates safety, immune biomarkers, and clinical effects of the investigational therapy, which targets the regulatory T cell pathway to modulate neuroinflam…
Ashland Inc. has introduced permexa™ sodium caprate, an intestinal permeation enhancer designed to support the scalable development and commercialization of oral peptide, biologic, and low-permeability drugs, including GLP-1 agonists. This innovation addresses manufacturing challenges such as formulation consistency and process robustness, and is i…
InterCure Ltd. announced a final settlement of approximately US$77 million related to indirect damages from the 2023 war, down from its initial claim of over US$100 million. The company plans to accelerate rebuilding its damaged Nir Oz facility, a critical production site, to return to full operations and support expanding supply to the German medi…
Wrap Technologies announced an expanded strategic relationship with Frenel Imaging to integrate advanced laser directed-energy counter-UAS technologies into its WrapShield platform, aiming to commercialize across U.S. and NATO markets. This move introduces mobile, scalable laser systems optimized for repeated drone engagements, addressing the evolv…
Biomea Fusion has completed enrollment in its COVALENT-211 Phase II trial evaluating icovamenib in insulin-deficient type 2 diabetes patients inadequately controlled on antihyperglycemic therapies. The trial enrolled 64 patients, assessing icovamenib's ability to restore beta-cell function and provide durable glycemic control, with topline results …
USA Rare Earth announced the completion of capitalization of a $1.55 billion Special Purpose Vehicle backed by the U.S. Government to purchase 100% of Phase 1 production from Serra Verde, a key rare earth producer. The Department of War committed $750 million, and the Company secured a $500 million senior debt facility, underpinning the acquisition…
X-Energy's subsidiary TRISO-X has begun the next phase of construction for its TX-1 advanced nuclear fuel fabrication facility in Oak Ridge, Tennessee. This facility will be the first commercial U.S. plant dedicated to TRISO fuel production for advanced reactors, supporting X-Energy's Xe-100 reactor deployments. The progress includes interior build…
Rapport Therapeutics, a clinical-stage biotech company focused on neurological and psychiatric disorders, announced a virtual key opinion leader (KOL) event for September 22, 2026, to discuss the unmet needs in treating bipolar mania and the development of its lead investigational drug RAP-219. The event will feature expert insights on the limitati…
Descartes Systems Group has acquired Tai, an AI-powered transportation management platform for freight brokers, for approximately $100 million. The acquisition enhances Descartes' transportation management offerings and expands its Global Logistics Network with advanced freight brokerage solutions. Tai’s platform automates freight operations and su…
Kratos Defense & Security Solutions announces expanded production of its Spartan J85 engines to supply Boeing's Joint Direct Attack Munition Long Range (JDAM LR) program after Boeing received a $75 million UCA from the US Air Force. The engines, produced in Kratos’ Auburn Hills facility, support precision-guided munitions with extended range and pa…
Monte Rosa Therapeutics has dosed the first patient in the MODeFIRe-1 Phase 2 clinical trial evaluating its investigational drug MRT-2359 combined with apalutamide in patients with AR mutation-positive metastatic castration-resistant prostate cancer (mCRPC). This follows encouraging Phase 1/2 data showing promising clinical responses in this diffic…
Gemini and Apex Fintech Solutions have signed a letter of intent for Gemini to become the exclusive CFTC-regulated venue for crypto event contracts distributed through Apex's Futures Commission Merchant to its brokerage clients. This collaboration leverages Gemini’s regulatory milestones to enable brokering both crypto and potentially other event c…
ANI Pharmaceuticals announces the appointment of Henry Gosebruch, an experienced biopharmaceutical executive, to its Board of Directors to strengthen corporate strategy and business development as it accelerates its transformation into a leading Rare Disease company. The company also notes a board resignation but retention in executive roles, highl…
